Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  16 (2024)
Volume  15 (2023)
Volume  14 (2022)
Volume  13 (2021)
Volume  12 (2020)
Volume  11 (2019)
Volume  10 (2018)
Volume  9 (2017)
Volume  8 (2016)
Volume  7 (2015)
Volume  6 (2014)
Volume  5 (2013)
Volume  4 (2012)
Volume  3 (2011)
Volume  2 (2010)
Volume  1 (2009)
Related articles

VOLUME 16 , ISSUE S3 ( December, 2024 ) > List of Articles

RESEARCH ARTICLE

Fertility Preservation in Men with Malignancies: An Experience at a Level II ART Clinic

Kunur Shah, Rohina S Aggarwal, Sumesh D Choudhary, Priyanka H Rane, Manisha Chhetry

Keywords : Cancer, Fertility preservation, Semen preservation

Citation Information :

DOI: 10.5005/jp-journals-10006-2474

License: CC BY-NC 4.0

Published Online: 03-02-2025

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Background: The advancement of cancer treatment has necessitated the need to address patients’ fertility concerns, as patients have a higher chance of survival, and most treatment modalities have an impact on their fertility. Semen freezing has long been considered the gold standard for male fertility preservation. Aim: To assess the profile of male cancer patients referred to the Institute of Kidney Diseases and Research Center (IKDRC) for fertility preservation, as well as analyze their semen parameters and return rate. Materials and methods: This study was a retrospective review and analysis of all male cancer referrals to IKDRC for fertility preservation from January 2020 to December 2023. Results: A total of 80 patients with malignancies underwent semen analysis with the aim of fertility preservation by semen analysis. The mean age of patients was 24.44 ± 5.39 years. The most common malignancy was testicular malignancy (31%), followed by Hodgkin's lymphoma (20.7%). About 51.2% of patients had normal semen analysis, while the most common abnormality was oligoasthenoteratozoospermia (OAT) observed in 17.5% of patients. No patients returned for the utilization of frozen semen samples during the study period. Conclusion: Testicular malignancy was the most common malignancy in young men seeking fertility care. Oligoasthenoteratozoospermia was the prevalent abnormality noted, and the returns rate for the use of stored semen samples was poor. However, longer follow-up is required to comment on the reproductive outcome.

PDF Share
  1. Ferlay J, Ervik M, Lam F, et al. Global cancer observatory: Cancer today. Lyon, France: International Agency for Research on Cancer. 2024. Available at: https://gco.iarc.who.int/media/globocan/factsheets/cancers/39-all-cancers-fact-sheet.pdf.
  2. Sathishkumar K, Chaturvedi M, Das P, et al. Cancer incidence estimates for 2022 & projection for 2025: Result from National Cancer Registry Programme, India. Indian J Med Res 2022;156(4&5):598–607. DOI: 10.4103/ijmr.ijmr_1821_22.
  3. Hendry WF, Stedronska J, Jones CR, et al. Semen analysis in testicular cancer and Hodgkin's disease: Pre- and post-treatment findings and implications for cryopreservation. Br J Urol 1983;55(6):769–773. DOI: 10.1111/j.1464-410x.1983.tb03423.x.
  4. Selby P, Brada M, Horwich A, et al. Semen cryopreservation for patients surviving malignant disease: Implications of proposed legislation. Lancet 1988;2(8621):1197. DOI: 10.1016/s0140-6736(88)90266-8.
  5. Howell SJ, Shalet SM. Spermatogenesis after cancer treatment: Damage and recovery. J Natl Cancer Inst Monogr 2005;(34):12–17. DOI: 10.1093/jncimonographs/lgi003.
  6. Holoch P, Wald M. Current options for preservation of fertility in the male. Fertil Steril 2011;96(2):286–290. DOI: 10.1016/j.fertnstert.2011.06.028.
  7. European Society of Human Reproduction and Embryology (ESHRE). Female fertility preservation: Guideline of the European Society of Human Reproduction and Embryology. 2020. Available from: https://www.eshre.eu/-/media/sitecore-files/Guidelines/Female-fertility-preservation/ESHRE-FFP-Guideline_2020.pdf.
  8. Reza S. The New 2010 WHO manual and the need to address some related dilemmas. J Reprod Infertil 2010;11(3):159. PMID: 23926483.
  9. National Cancer Institute. Surveillance, epidemiology, and end results program. Cancer Statistics Review. 2009. Available from: http://www.seer.cancer.gov/statfacts.
  10. Landis SH, Murray T, Bolden S, et al. Cancer statistics, 1999. CA Cancer J Clin 1999;49(1):8–31. DOI: 10.3322/canjclin.49.1.8.
  11. Liu X, Liu B, Liu S, et al. Male cancer patient sperm cryopreservation for fertility preservation: 10-year monocentric experience. Basic Clin Androl 2021;31(1):24. DOI: 10.1186/s12610-021-00140-w.
  12. Schover LR, Brey K, Lichtin A, et al. Knowledge and experience regarding cancer, infertility, and sperm banking in younger male survivors. J Clin Oncol 2002;20(7):1880–1889. DOI: 10.1200/JCO.2002.07.175.
  13. Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 2006;24(18):2917–2931. DOI: 10.1200/JCO.2006.06.5888.
  14. Loren AW, Mangu PB, Beck LN, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013;31(19):2500–2510. DOI: 10.1200/JCO.2013.49.2678.
  15. Jivarajani PJ, Patel HV, Mecwan RR, et al. Major sites of cancer occurrence among men and women in Gandhinagar district, India. Indian J Community Med 2015;40(1):56–61. DOI: 10.4103/0970-0218.149273.
  16. Pereira ML, Garcia e Costa F. The blood-testis barrier as a target of some chemotherapeutic agents. Chemotherapy 2007;53(6):446–448. DOI: 10.1159/000110017.
  17. Aubier F, Flamant F, Brauner R, et al. Male gonadal function after chemotherapy for solid tumors in childhood. J Clin Oncol 1989;7(3):304–309. DOI: 10.1200/JCO.1989.7.3.304.
  18. Wallace WH, Anderson RA, Irvine DS. Fertility preservation for young patients with cancer: Who is at risk and what can be offered? Lancet Oncol 2005;6(4):209–218. DOI: 10.1016/S1470-2045(05)70092-9.
  19. Rivkees SA, Crawford JD. The relationship of gonadal activity and chemotherapy-induced gonadal damage. JAMA 1988;259(14): 2123–2125. PMID: 3162285.
  20. Shalet SM. Effect of irradiation treatment on gonadal function in men treated for germ cell cancer. Eur Urol 1993;23(1):148–151. DOI: 10.1159/000474584.
  21. Rowley MJ, Leach DR, Warner GA, et al. Effect of graded doses of ionizing radiation on the human testis. Radiat Res 1974;59(3):665–678. PMID: 4428015.
  22. Skaznik-Wikiel ME, Gilbert SB, Meacham RB, et al. Fertility preservation options for men and women with cancer. Rev Urol 2015;17(4):211–219. PMID: 26839518.
  23. Bonetti TC, Pasqualotto FF, Queiroz P, et al. Sperm banking for male cancer patients: Social and semen profiles. Int Braz J Urol 2009;35(2):190–197. DOI: 10.1590/s1677-55382009000200009.
  24. Botchan A, Hauser R, Gamzu R, et al. Sperm quality in Hodgkin's disease versus non-Hodgkin's lymphoma. Hum Reprod 1997;12(1): 73–76. DOI: 10.1093/humrep/12.1.73.
  25. Moody JA, Ahmed K, Yap T, et al. Fertility managment in testicular cancer: The need to establish a standardized and evidence-based patient-centric pathway. BJU Int 2019;123(1):160–172. DOI: 10.1111/bju.14455.
  26. van Casteren NJ, Boellaard WP, Romijn JC, et al. Gonadal dysfunction in male cancer patients before cytotoxic treatment. Int J Androl 2010;33(1):73–79. DOI: 10.1111/j.1365-2605.2009.00956.x.
  27. Oktay K, Harvey BE, Partridge AH, et al. Fertility preservation in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol 2018;36(19):1994–2001. DOI: 10.1200/JCO.2018.78.1914.
  28. Tournaye H, Goossens E, Verheyen G, et al. Preserving the reproductive potential of men and boys with cancer: Current concepts and future prospects. Hum Reprod Update 2004;10(6):525–532. DOI: 10.1093/humupd/dmh038.
  29. van Casteren NJ, van Santbrink EJ, van Inzen W, et al. Use rate and assisted reproduction technologies outcome of cryopreserved semen from 629 cancer patients. Fertil Steril 2008;90(6):2245–2250. DOI: 10.1016/j.fertnstert.2007.10.055.
  30. Neal MS, Nagel K, Duckworth J, et al. Effectiveness of sperm banking in adolescents and young adults with cancer: A regional experience. Cancer 2007;110(5):1125–1129. DOI: 10.1002/cncr.22889.
  31. Kelleher S, Wishart SM, Liu PY, et al. Long-term outcomes of elective human sperm cryostorage. Hum Reprod 2001;16(12):2632–2639. DOI: 10.1093/humrep/16.12.2632.
  32. Dearing C, Breen D, Bradshaw A, et al. Trends and usage in a London National Health Service Sperm Bank for cancer patients. Hum Fertil (Camb) 2014;17(4):289–296. DOI: 10.3109/14647273.2014.948499.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.